Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC43H61N9O7S |
InChIKeyDPADMHBFWQPZCN-PIFNACGGSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | JP | 26 Apr 2017 | |
Neoplasms | Preclinical | JP | 26 Apr 2017 |